Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Icahn School of Medicine at Mount Sinai
Massachusetts General Hospital
Genzada Pharmaceuticals USA, Inc.
ImmVira Pharma Co. Ltd
Merrimack Pharmaceuticals
AHS Cancer Control Alberta
National Cancer Institute (NCI)